Nuformix plc
NFX.L · LSE
9/30/2024 | 9/30/2023 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | – | £50 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | £0 | £37 | – | £39 |
| Gross Profit | £0 | -£37 | – | £11 |
| % Margin | – | – | – | 22.7% |
| R&D Expenses | £71 | £163 | – | £573 |
| G&A Expenses | £506 | £619 | – | £1 |
| SG&A Expenses | £506 | £619 | – | £709 |
| Sales & Mktg Exp. | £0 | £0 | – | £707 |
| Other Operating Expenses | £3,070 | -£163 | – | £0 |
| Operating Expenses | £3,647 | £619 | – | £1,282 |
| Operating Income | -£3,647 | -£619 | – | -£1,270 |
| % Margin | – | – | – | -2,540.5% |
| Other Income/Exp. Net | £0 | £0 | – | £0 |
| Pre-Tax Income | -£3,647 | -£619 | – | -£1,270 |
| Tax Expense | -£6 | -£46 | – | -£161 |
| Net Income | -£3,641 | -£573 | – | -£1,109 |
| % Margin | – | – | – | -2,218% |
| EPS | -0.005 | -0.001 | – | -0.002 |
| % Growth | -475% | – | – | – |
| EPS Diluted | -0.005 | -0.001 | – | -0.002 |
| Weighted Avg Shares Out | 787,008 | 719,462 | – | 598,448 |
| Weighted Avg Shares Out Dil | 786,932 | 719,462 | – | 598,448 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | – | £0 |
| Interest Expense | £0 | £0 | – | £0 |
| Depreciation & Amortization | £29 | £37 | – | £37 |
| EBITDA | -£477 | -£582 | – | -£1,233 |
| % Margin | – | – | – | -2,466.6% |